Home » Topics » BioWorld Science

BioWorld Science
RSS

Termination of PSVT with CVT-510 associated with fewer arrhythmias than adenosine

Nov. 14, 2001

FDA approves frovatriptan for treatment of migraine

Nov. 14, 2001

Prevention of carotid artery intimal hyperplasia by oral chymase inhibitor

Nov. 14, 2001

New caspase inhibitor limits infarct size in rat model of cardiac ischemia/reperfusion injury

Nov. 14, 2001

Lundbeck offers interim progress report

Nov. 14, 2001

Factor Xa inhibitor as a novel therapeutic agent in embolic stroke

Nov. 14, 2001

Neurochemical effects of selective, oral AChE inhibitor from Chiesi studied in rats

Nov. 14, 2001

Preclinical evidence supports the therapeutic potential of dexefaroxan in AD

Nov. 14, 2001

Antioxidant strategy based on targeted enzyme induction may be beneficial in MS

Nov. 14, 2001

Traditional medicine used in Korea inhibits behavioral effects of psychostimulants

Nov. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...